Link do poprzedniego wątku spółki znajduje się tutaj: http://forum.parkiet.com/viewtopic.php?t=207003
Kurs zamknięcia z ostatniej sesji to: 48,40 PLN
W tym wątku będziemy z niecierpliwością oczekiwać na podpisania przez Mabion umowy dystrybucyjnej na obszar UE dla leku MabionCD20. Leku, który ma szansę być pierwszym biopodobnym odpowiednikiem leku rituximab (Mabthera/Rituxan) w UE
Biosimilar rituximab race (highly regulated markets)
Final data collection date for primary outcome measure:
1. MabionCD20 - Mabion - Total Estimated Enrollment: 863 (Phase 3)
March 2016 - https://clinicaltrials.gov/ct2/show/NCT02468791 Estimated Enrollment: 863
2. PF-05280586 - Pfizer - Total Estimated Enrollment: 394 (Phase 3)
November 2016 - https://clinicaltrials.gov/ct2/show/NCT02213263 Estimated Enrollment: 394
3. BI 695500 - Boehringer Ingelheim - Total Est. Enrollment: 556 (Phase 3)
March 2017 - https://clinicaltrials.gov/ct2/show/NCT02417129 Estimated Enrollment: 250
December 2016 - https://clinicaltrials.gov/ct2/show/NCT01955733 Open-label Extension Trial
July 2016 - https://clinicaltrials.gov/ct2/show/NCT01682512 Estimated Enrollment: 306
4. GP2013 - Sandoz - Total Estimated Enrollment: 718 (Phase 3)
December 2017 - https://clinicaltrials.gov/ct2/show/NCT01419665 Estimated Enrollment: 618
December 2016 - https://clinicaltrials.gov/ct2/show/NCT02514772 Estimated Enrollment: 100
5. CT-P10 - Celltrion - Total Estimated Enrollment: 654 (Phase 3)
March 2018 - https://clinicaltrials.gov/ct2/show/NCT02260804 Estimated Enrollment: 104
February 2017 - https://clinicaltrials.gov/ct2/show/NCT02162771 Estimated Enrollment: 250
January 2017 - https://clinicaltrials.gov/ct2/show/NCT02149121 Estimated Enrollment: 300
Compiled only:
- biosimilar rituximab candidates in phase 3 studies
- studies with a total enrollment of 300 and above
- studies in the ClinicalTrials.gov only
Compiled: July 19, 2015 by Mabion_3mldEUR_2019r
Last updated: September 29, 2015 by Mabion_3mldEUR_2019r
Rituximab (Mabthera/Rituxan) was the fourth best selling drug in the world in 2014:
http://www.genengnews.com/keywordsandto ... t/3/37387/
